Heat Biologics, Inc. Reports 2014 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
Heat Biologics (HTBX) Posts Q2 Loss of 44c/Share
August 14, 2014 7:15 AM EDTHeat Biologics (NASDAQ: HTBX) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Heat Biologics (HTBX) click here.
... More


